DermaGen AB

Quick facts

Phase 2 pipeline

• DPK-060 · Dermatology
  DPK-060 is a topical treatment that modulates the immune response to reduce inflammation.

Phase 1 pipeline

• DPK-060 1% ointment

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• DermaGen AB portfolio CI brief
• DermaGen AB pipeline updates RSS

Related

• Sector hub: All tracked pharma companies